Hematology 425 Megakaryopoiesis - PowerPoint PPT Presentation

1 / 32
About This Presentation
Title:

Hematology 425 Megakaryopoiesis

Description:

As with RBCs and WBCs, megakaryocytes develop from a PSC influenced by CSFs ... factors, especially factor I (fibrinogen) and factor V (labile factor) ... – PowerPoint PPT presentation

Number of Views:1488
Avg rating:3.0/5.0
Slides: 33
Provided by: russellm5
Category:

less

Transcript and Presenter's Notes

Title: Hematology 425 Megakaryopoiesis


1
Hematology 425 Megakaryopoiesis
  • Russ Morrison
  • October 13, 2006

2
Megakaryopoiesis
  • Platelets (thrombocytes) are cytoplasmic
    fragments that are released from a parent cell
    known as a megakaryocyte
  • Megakaryocytes are large, 80-150 um
  • Megakaryocytes are found predominantly in the BM
    and to a lesser degree in the spleen and lungs
  • As with RBCs and WBCs, megakaryocytes develop
    from a PSC influenced by CSFs
  • These CSFs are produced by macrophages,
    fibroblasts, T lymphocytes, and stimulated
    endothelial cells

3
Megakaryopoiesis
  • As with RBCs and WBCs, interleukins play an
    influential role, particularly IL-3, IL-6 and
    IL-11
  • Meg-CSF and G-CSF together stimulate production
    of megakaryocyte progenitor cells
  • Meg-CSF is thourhg to be produced by
  • BM cells in response to the megakaryocytic mass.

4
Megakaryopoiesis
  • As the number of megakaryocytes decrease, the
    production of Meg-CSF increases
  • Thrombopoietin is generated by the kidney with a
    lesser amount produced by the liver and spleen
  • Thrmbopoietin binds to its receptor, C-mpl, and
    stiulates megakaryocyte growth and platelet
    production
  • Thrombopoietin also stimulates the release of
    platelets from the megakaryocyte

5
Megakaryopoiesis
  • Role of the spleen in platelet production
  • The spleen plays a key role in the regulation of
    platelet numbers
  • 30 of the PB platelets are sequestered in the
    spleen at any given time
  • Rapid use of platelets through clotting or
    destruction rapidly empties the splenic pool
  • When the platelet count decreases, thrombopoietin
    causes maturation of the megakaryocyte to produce
    a marrow response equal to the loss of platelets

6
Megakaryopoiesis
  • Any increase in thrombopoietin speeds up the
    maturation of megakaryocytes
  • Accelerated maturation results in fewer platelets
    produced per megakaryocyte
  • Sustained usage/destruction of platelets causes
    the platelet count to fall to a level incapable
    of maintaining normal vascular and hemostatic
    integrity
  • This results in a condition called acute
    thrombocytopenia

7
Megakaryopoiesis
Platelet production is unique from other
hematopoietic cell production
  • Megakaryocytes do not experience complete
    cellular division, but undergo a proces called
    endomitosis
  • RBC and WBC precursors usually divide four times
    during maturation, producing 16 mature cells from
    each committed stem cell.

8
Megakaryopoiesis
  • In endomitosis, normal telophase is missing
    creating a cell with a multilobed nucleus
  • Each lobe of the nucleus is diploid, 2N, and
    contains a full complement of 23 pairs of
    chromosomes capable of transcription
  • Megakaryocytes are, therefore, polyploid (have
    more than 2 complete sets of chromosomes)

9
Megakaryopoiesis
  • During endomitotic division of the nucleus, the
    more ploidy there is, the larger the cytoplasmic
    volume will be
  • Megakaryocytes may achieve 16N, or 16 chromosome
    pairs and develop as many as 16 lobes, 32N
  • When the platelet turnover is in equilibrium, the
    average megakaryocyte which is 8N or 16N,
    produces 2000 to 4000 platelets

10
Megakaryopoiesis
  • The maturation process of the Megakaryocyte is
    from PSC to megakaryoblast to basophilic
    cytoplasmic fragments which are later release as
    platelets
  • The first in the maturation sequence is called
    the megakaryoblast or MK1 cell

11
Megakaryopoiesis
  • Megakaryoblast (MK1)
  • 10-15 um in size
  • High nuclear to cytoplasmic ratio
  • Single nucleus with 2-6 nucleoli
  • Cytoplasm is minimal, blue, and contains not
    granules
  • Not distinguishable bo microscopy alone
  • At this stage may reach 50 um in size

12
Megakaryopoiesis
  • Promegakaryocyte (MK2)
  • Reaches 80 um in size
  • Develops three kinds of granules formed in the
    Golgi apparatus
  • Granules are termed dense, alpha and lysosomal
    and are dispersed throught the cytpolasm

13
Megakaryopoiesis
  • Basophilic Megakaryocyte (MK3)
  • Final divisions of the nucleus occur
  • Distinct granulation patterns develop
  • Cytoplasmic separation lines begin to be seen,
    outlining individual cytoplasmic fragments which
    will later be released as platelets
  • Each demarcated area consists of a membrane,
    cytoskeleton, system of microtubules, canals and
    a portion of cytoplasmic granules and also has a
    store of glycogen to sustain the platelet for
    9-11 days

14
Megakaryopoiesis
  • Basophilic Megakaryocyte (MK3)
  • The cytoplasmic fragments further develop a
    membrane with several types of glycoprotein
    receptors
  • These receptors which develop during this stage
    allow activation, adherence, aggregation, and
    cross-linking of the platelet

15
Megakaryopoiesis
  • Megakaryocyte (MK4)
  • Final stage of cell line maturation
  • The mature megakaryocyte releases cytoplasmic
    fragments through marrow sinusoid fenestrations
    in a process called budding or shedding of the
    platelets
  • When all platelets are released into the blood
    stream, the naked nucleus that remains is
    phagocytized by marrow histiocytes

16
Megakaryopoiesis
  • Megakaryocyte (MK4)
  • Since thousands of platelets are shed from each
    mature megakaryocyte, fewer progenitor cells are
    needed compared to the other cell lines
  • Megakaryocytes, because of their size, are
    quickly evident when present on a BM smear
  • Presence of megakaryocytes in the BM without
    searching, indicates adequate production

17
Megakaryopoiesis
  • Megakaryocyte (MK4)
  • Megakaryocytic hyperplasia indicates normal
    response to increased demand or autonomous
    proliferation as is seen in myeloproliferative
    disease
  • Clustering of megakaryocytes is usually seen in
    myeloproliferative diseases

18
Platelet Structure
  • Platelets entering the peripheral blood have an
    average diameter of 2.5 um
  • Unstimulated platelets are lentiform discs with
    smooth margins
  • Platelet structure can be divided into
    peripheral, sol-gel, organelle and membrane zones
  • EM work has defined the zones as well as the
    structures contained in each zone

19
Platelet Structure
  • Peripheral Zone
  • Includes the platelet membrane which contains
    membrane-bound glycoproteins, an exterior coat
    called the glycocalyx and a cytoskeleton packed
    with actin and myosin fibrils and microtubules
  • The glycoproteins of the platelet membrane
    function similarly to those of the RBC

20
Platelet Structure
  • Peripheral Zone
  • The glycocalyx is a coat of side chains
    protruding beyond the membrane surface and
    connected to the glycoproteins
  • The glycocalyx possesses platelet ABO and HLA
    antigens which act as receptors for thrombin,
    vWF, epinephrine, ADP and platelet-activating
    factor (PAF)

21
Platelet Structure
  • Peripheral Zone
  • The activated platelet changes shape from smooth
    margined discs to spiny projections
  • The microtubules and the cytoskeleton represent
    an extension of the platelet membrane winding
    inwardly throughout the platelet interior

22
Platelet Structure
  • Sol-Gel
  • During activation and constriction of platelets,
    the open canalicular system (OCS) delivers the
    granular contents to the surface
  • Multiple pores of the OCS connect internal
    contents of the platelet with the surface
  • As the platelet circulates through the blood
    stream, the pores also allow plasma to enter the
    microtubules facilitating absorption of plasma
    coagulation factors

23
Platelet Structure
  • Sol-Gel
  • Alpha granules concentrate coagulation factors,
    especially factor I (fibrinogen) and factor V
    (labile factor)
  • Megakaryocytes do not synthesize plasma clotting
    factors, but platelets acquire them circulating
    through the blood
  • Other blood clotting factors are collected on the
    surface of the platelet and held their by surface
    tension
  • When platelets become activated, they have
    clotting factors already available by these
    mechanisms

24
Platelet Structure
  • Sol-Gel
  • The sol-gel zone also includes a dense tubular
    system which is the primary site of sequestration
    of calcium ions
  • The calcium becomes the source to drive
    calcium-dependent reactions of coagulation

25
Platelet Structure
  • Organelle Zone
  • The interior of the platelet contains
    mitochondria, lysosomes, dense granules and alpha
    granules that are released during platelet
    activity
  • The mitochondria provide oxidative
    phosphorylation of ATP energy through their
    glycolytic and citric acid cycles (EM and Krebs,
    respectively)
  • Breakdown of glycogen is necessary to produce the
    ATP needed to change shape or reverse activation
    of the platelet

26
Platelet Structure
  • Organelle Zone
  • Platelet granules are filled with constituents
    released in various phases of hemostasis
  • Shape change and calcium mobilization during
    platelet activation assist the dense granules in
    releasing their contents
  • The alpha granules release their contents next

27
Platelet Structure
  • Organelle Zone
  • Alpha granules platelet-derived growth factor
    (PDGF) that causes proliferation of endothelial,
    smooth muscle, and fibroblast cells for the
    inflammation and repair process
  • Alpha granules also release thrombospondin, a
    large (450-kD) glycoprotein that appears to
    enhance platelet adherence and aggregation by
    attaching to corresponding platelet receptors
  • Thrombospondin is instrumental in facilitating
    cell-to-cell interactions by use of its receptor
    for platelet attachment

28
Platelet Structure
  • Organelle Zone
  • Other compounds released from alpha granules
    inhibit heparin released by mast cells and
    basophils
  • Those compounds are platelet factor 4 (PF4) and
    beta-thromboglobulin (BTG)
  • Both prevent heparin neutralization of thrombin
    and other clotting enzymes
  • Alpha granules also release an inhibitor called
    plasminogen activator inhibitor-a that
    neutralizes tissue plasminogen activator released
    by traumatized endothelial cells

29
Platelet Structure
  • Surface marker
  • CMP-140 is an acquired membrane marker of
    platelets that is found on active, but not
    resting platelets
  • CMP-140 is thought to be remnants of alpha
    granule membrane bound to the platelet surface
  • Flow cytometry can identify this marker and
    differentiate resting and active platelets

30
Platelet Structure
  • Receptors
  • Several glycoprotein receptors have been
    identified on the platelet membrane and internal
    surface
  • The membrane receptors initiate the complex
    communication system of signal transduction
  • Laboratory evaluation of platelet agonists is
    done with one stimulus at a time and is
    demonstrated in platelet aggregation studies

31
Platelet Structure
  • Glycoprotein receptors of the platelet include
    ADP, thrombin, vWF, collagen, fibrinogen, fibrin,
    fibrinectin, epinephrine, PAF, thrombospondin,
    and others
  • One of the receptor complexes (GPIIb/IIIa) is the
    receptor for fibrinogen and fibronectin, with vWF
    helping platelets adhere and cross-link together
    in a stabilized plug with plasminogen

32
Platelet Structure
  • If you want to read ahead and begin to connect
    platelets and clotting factors and their
    interrelationships in hemostasis, begin with
    Chapter 42
Write a Comment
User Comments (0)
About PowerShow.com